BCRX | BioCryst Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31
Revenue	331.41M	270.83M	157.17M	17.81M	48.84M	20.65M	25.19M	26.35M	48.26M	13.61M	17.33M	26.29M	19.64M	63.50M	74.59M	56.56M	71.24M	6.21M	151.87K	336.90K	1.63M	1.77M	11.16M	3.32M	2.50M	6.40M	1.00M	2.70M	200.00K	700.00K
Cost of Revenue	4.66M	6.59M	7.26M	1.68M	4.10M	471.00K	1.70M	2.70M	1.90M	122.00K	98.00K	132.00K	N/A	86.00K	4.54M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-500.00K	-500.00K	-600.00K	7.10M	6.50M	5.00M
Gross Profit	326.75M	264.23M	149.91M	16.14M	44.73M	20.18M	23.48M	23.65M	46.36M	13.49M	17.23M	26.16M	19.64M	63.41M	70.05M	56.56M	71.24M	6.21M	151.87K	336.90K	1.63M	1.77M	11.16M	3.32M	3.00M	6.90M	1.60M	-4.40M	-6.30M	-4.30M
Operating Expenses	430.46M	412.67M	327.63M	190.89M	144.19M	114.40M	80.89M	72.26M	85.81M	59.26M	47.95M	58.29M	69.23M	96.65M	83.78M	83.73M	103.52M	53.19M	27.33M	22.09M	14.33M	18.33M	16.14M	13.15M	11.10M	12.90M	13.90M	3.20M	2.80M	2.50M
Selling, General & Admin	213.89M	159.37M	118.82M	67.93M	37.12M	29.51M	13.93M	11.25M	13.05M	7.46M	5.22M	6.83M	12.33M	14.18M	11.48M	10.40M	9.47M	6.11M	3.69M	3.21M	2.81M	2.86M	3.05M	3.56M	2.90M	3.10M	2.70M	2.70M	2.20M	1.90M
Research & Development	216.57M	253.30M	208.81M	122.96M	107.07M	84.89M	66.96M	61.01M	72.76M	51.80M	42.73M	51.46M	56.90M	82.47M	72.30M	73.33M	94.05M	47.08M	23.64M	18.87M	11.52M	15.47M	13.09M	9.59M	7.70M	9.30M	10.60M	N/A	N/A	N/A
Other Operating Expenses	N/A	253.27M	202.92M	111.96M	82.44M	70.81M	54.38M	47.01M	33.71M	41.37M	28.06M	30.38M	37.26M	N/A	N/A	N/A	N/A	N/A	N/A	8.34K	N/A	N/A	N/A	N/A	500.00K	500.00K	600.00K	500.00K	600.00K	600.00K
Operating Income	-103.71M	-148.44M	-177.72M	-174.76M	-99.45M	-94.22M	-57.41M	-48.61M	-39.44M	-45.77M	-30.72M	-33.89M	-49.59M	-33.24M	-13.74M	-27.16M	-32.28M	-46.98M	-27.18M	-21.75M	-12.70M	-16.55M	-4.99M	-9.83M	-8.10M	-6.00M	-12.30M	-7.60M	-9.10M	-6.80M
Other Expenses / Income	-122.52M	-95.95M	-4.09M	-8.06M	-9.44M	-7.03M	-8.37M	-6.54M	-3.58M	582.00K	609.00K	-5.19M	-7.36M	503.54K	285.69K	2.43M	3.22M	-26.05B	27.18M	647.75K	-12.69B	18.70M	-4.98B	-11.57B	1.20M	1.30M	1.70M	N/A	700.00K	N/A
Before Tax Income	-226.23M	-244.38M	-181.81M	-182.81M	-108.90M	-101.25M	-65.78M	-55.14M	-43.02M	-45.19M	-30.11M	-39.08M	-56.95M	-33.85B	-13.45M	-24.73M	-29.05M	-26.10B	-26.10B	-21.10B	-12.70B	-16.93B	-4.99B	-11.58B	-6.90M	-4.70M	-10.60M	N/A	-8.40M	N/A
Income Tax Expenses	310.00K	2.73M	2.25M	13.75M	11.17M	2.14M	7.86M	6.00M	5.02M	4.82M	4.47M	4.04M	6.47M	500.76M	-1.61M	-430.00	524.00	-26.06B	1.08B	-647.75K	-12.69B	373.90K	-4.98B	-11.57B	-2.80M	-1.20M	-1.70M	100.00K	-500.00K	100.00K
Net Income	-226.54M	-247.12M	-184.06M	-196.57M	-120.06M	-101.25M	-65.78M	-55.14M	-43.02M	-45.19M	-30.11M	-39.08M	-56.95M	-32.73M	-13.45M	-24.73M	-29.06M	-43.62M	-26.10M	-21.10M	-12.70M	-16.93M	-4.99M	-11.58M	-5.30M	-4.80M	-10.60M	-7.70M	-8.60M	-6.90M
Interest Expenses	108.24M	99.09M	59.29M	14.50M	11.89M	9.18M	8.56M	6.49M	5.20M	5.00M	4.78M	4.67M	3.77M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	192.20M	185.91M	179.12M	167.27M	115.60M	103.19M	84.45M	73.70M	72.90M	66.77M	55.22M	49.47M	45.14M	44.56M	38.93M	38.06M	32.77M	29.15M	25.72M	21.17M	17.70M	17.64M	17.56M	17.47M	15.38M	14.12M	13.78M	11.16M	8.96M	6.76M
Diluted Shares Outstanding	192.20M	185.91M	179.12M	167.27M	115.60M	103.19M	84.45M	73.70M	72.90M	66.77M	55.22M	49.47M	45.14M	44.56M	38.93M	38.06M	32.77M	29.15M	25.72M	21.17M	17.70M	17.64M	17.56M	18.96M	15.38M	14.12M	13.78M	11.16M	8.96M	6.76M
EBITDA	-116.33M	-143.85M	-121.74M	-167.56M	-96.28M	-90.36M	-56.51M	-48.17M	-37.64M	-40.01M	-25.03M	-33.79M	-52.29M	-31.59M	-11.84M	-23.11M	-27.69M	-42.80M	-25.23M	-20.13M	-12.58M	-17.46M	-3.94M	-9.16M	-7.60M	-5.50M	-11.70M	-8.20M	-8.50M	-6.20M
EBITDA Margin	-35.10%	-53.12%	-77.46%	-940.74%	-197.16%	-437.54%	-224.38%	-182.80%	-78.00%	-294.05%	-144.40%	-128.50%	-266.19%	-49.74%	-15.87%	-40.85%	-38.86%	-688.94%	-16,615.99%	-5,976.44%	-769.82%	-983.73%	-35.28%	-276.35%	-304.00%	-85.94%	-1,170.00%	-303.70%	-4,250.00%	-885.71%
EBIT	-117.99M	-145.29M	-122.52M	-168.31M	-97.00M	-89.93M	-49.36M	-42.65M	-32.80M	-35.37M	-20.86M	-30.38M	-46.70M	468.03M	-15.06M	-24.73M	-29.05M	-26.10B	1.05B	-21.75M	-12.70B	-16.55M	-4.99B	-11.58B	-8.10M	-6.00M	-12.30M	-7.60M	-9.10M	-6.80M
EBIT Margin	-35.60%	-53.65%	-77.95%	-944.94%	-198.64%	-435.44%	-195.97%	-161.85%	-67.97%	-259.92%	-120.34%	-115.53%	-237.74%	737.04%	-20.20%	-43.73%	-40.79%	-420,139.04%	691,979.28%	-6,456.46%	-777,238.86%	-932.91%	-44,686.68%	-349,193.60%	-324.00%	-93.75%	-1,230.00%	-281.48%	-4,550.00%	-971.43%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31